|
|
|
|
Lifeloc Technologies Inc (LCTC) |
|
|
|
| |
Lifeloc Technologies Inc 's Working Capital Ratio
LCTC's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth
Regardless of the sequential decrease in Current Liabilities, during the first quarter 2024, Working Capital Ratio deteriorated to 5.59 below Lifeloc Technologies Inc 's average Working Capital Ratio.
Within Laboratory Analytical Instruments industry 9 other companies have achieved higher Working Capital Ratio than Lifeloc Technologies Inc in first quarter 2024. While Working Capital Ratio total ranking in the first quarter 2024 has deteriorated compared to the prior quarter from 764 to 803.
Explain Working Capital Ratio
How much Current Assetss LCTC´s has?
What are LCTC´s Current Liabilities?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| LCTC Working Capital Ratio |
(Mar 31 2024)
Q1 |
(Dec 31 2023)
Q4 |
(Sep 30 2023)
Q3 |
(Jun 30 2023)
Q2 |
(Mar 31 2023)
Q1 |
| Y / Y Current Liabilities Change |
5.17 % |
1.92 % |
15.27 % |
11.21 % |
38.92 % |
| Y / Y Current Assets Change |
-12.25 % |
-2.88 % |
7.69 % |
6.93 % |
5.13 % |
| Working Capital Ratio MRQ |
5.59 |
5.99 |
6.28 |
7.41 |
6.7 |
| LCTC's Total
Ranking |
# 803 |
# 764 |
# 540 |
# 312 |
# 491 |
| Seq. Current Liabilities Change |
-4.9 % |
-0.54 % |
22.67 % |
-9.35 % |
-7.85 % |
| Seq. Current Assets Change |
-11.15 % |
-5.22 % |
4.08 % |
0.12 % |
-1.67 % |
| Working Capital Ratio first quarter 2024 Company Ranking |
| Within: |
No. |
| Laboratory Analytical Instruments Industry |
# 10 |
| Healthcare Sector |
# 361 |
| Overall Market |
# 803 |
| Working Capital Ratio Statistics |
| High |
Average |
Low |
| 10.39 |
6.4 |
4.07 |
| (Sep 30 2021) |
|
(Dec 31 2020) |
Cumulative Lifeloc Technologies Inc 's Working Capital Ratio
LCTC's Working Capital Ratio for the trailling 12 Months
LCTC Working Capital Ratio |
(Mar 31 2024)
12 Months |
(Dec 31 2023)
12 Months |
(Sep 30 2023)
12 Months |
(Jun 30 2023)
12 Months |
(Mar 31 2023)
12 Months |
| Y / Y Current Liabilities TTM Growth |
8.05 % |
15.05 % |
15.39 % |
21.83 % |
0.6 % |
| Y / Y Current Assets TTM Growth |
-0.32 % |
4.1 % |
4.95 % |
1.74 % |
-1.39 % |
| Working Capital Ratio TTM |
6.27 |
6.55 |
6.63 |
6.75 |
6.8 |
| Total Ranking TTM |
# 3783
| # 329
| # 498
| # 3768
| # 3776
|
| Seq. Current Liabilities TTM Growth |
1.25 % |
0.51 % |
3.72 % |
2.36 % |
7.81 % |
| Seq. Current Assets TTM Growth |
-3.04 % |
-0.72 % |
1.87 % |
1.66 % |
1.26 % |
On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2024 to $0.91 millions, cumulative Working Capital Ratio decreased to 6.27 above the LCTC average Working Capital Ratio. Working Capital Ratio is the average cumulative value over the last four quarters.
Among companies operating within Laboratory Analytical Instruments industry 29 other companies have achieved higher Working Capital Ratio than Lifeloc Technologies Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the forth quarter 2023 from 329 to 3783.
Explain Working Capital Ratio
How much Current Assetss LCTC´s has?
What are LCTC´s Current Liabilities?
| TTM Working Capital Ratio Company Ranking |
| Within: |
No. |
| Within the Laboratory Analytical Instruments Industry |
# 30 |
| Healthcare Sector |
# 1003 |
| Within the Market |
# 3783 |
| trailing twelve months Working Capital Ratio Statistics |
| High |
Average |
Low |
| 7.2 |
6.02 |
4.38 |
| (Dec. 30, 2015) |
|
(Mar 31 2021) |
| Companies with similar Working Capital Ratio in the quarter ending Mar 31 2024, within Laboratory Analytical Instruments Industry | Working Capital Ratio | Mar 31 2024 MRQ Current Assets | Mar 31 2024 MRQ Current Liabilities | | Quanterix Corporation | 11.28 | $ 369.352 Millions | $ 32.757 Millions | | Pacific Biosciences Of California Inc | 9.28 | $ 677.024 Millions | $ 72.951 Millions | | Talis Biomedical Corporation | 7.51 | $ 71.170 Millions | $ 9.471 Millions | | Bio rad Laboratories Inc | 7.18 | $ 3,060.936 Millions | $ 426.116 Millions | | Cytek Biosciences Inc | 6.99 | $ 388.647 Millions | $ 55.566 Millions | | Rapid Micro Biosystems Inc | 6.93 | $ 108.160 Millions | $ 15.600 Millions | | Lifeloc Technologies Inc | 5.59 | $ 5.073 Millions | $ 0.907 Millions | | Scientific Industries Inc | 5.56 | $ 11.400 Millions | $ 2.050 Millions | | 10x Genomics Inc | 5.22 | $ 567.093 Millions | $ 108.733 Millions | | Eyepoint Pharmaceuticals Inc | 5.08 | $ 317.709 Millions | $ 62.580 Millions | | Standard Biotools Inc | 4.50 | $ 547.565 Millions | $ 121.554 Millions | | Reflect Scientific Inc | 3.66 | $ 2.396 Millions | $ 0.655 Millions | | Telesis Bio Inc | 3.65 | $ 23.395 Millions | $ 6.412 Millions | | Akoya Biosciences Inc | 3.07 | $ 101.829 Millions | $ 33.193 Millions | | Kewaunee Scientific Corporation | 2.37 | $ 96.817 Millions | $ 40.780 Millions | | Revvity Inc | 2.23 | $ 3,059.340 Millions | $ 1,374.222 Millions | | Agilent Technologies inc | 2.15 | $ 4,203.000 Millions | $ 1,958.000 Millions | | Harvard Bioscience Inc | 1.88 | $ 48.148 Millions | $ 25.677 Millions | | Bruker Corporation | 1.81 | $ 2,140.400 Millions | $ 1,182.500 Millions | | Illumina Inc | 1.75 | $ 2,583.000 Millions | $ 1,474.000 Millions | | Avantor Inc | 1.61 | $ 2,321.100 Millions | $ 1,441.900 Millions | | Accelerate Diagnostics Inc | 1.50 | $ 24.133 Millions | $ 16.131 Millions | | Bionano Genomics Inc | 1.46 | $ 85.611 Millions | $ 58.506 Millions | | Mettler toledo International Inc | 1.28 | $ 1,211.114 Millions | $ 948.759 Millions |
|
Date modified: 2024-09-02T11:06:20+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
